While adding DNA sequencing to the screening of newborns for hundreds of potential genetic diseases may help accurately identify babies who will develop a disease, it could be too early to recommend for the general public, say researchers.
Every baby born in the US is given a routine blood test to screen for dozens of inherited medical conditions.
Now, the US National Institutes of Health is exploring whether to use DNA sequencing to screen newborn babies for additional genetic abnormalities and disorders. Such DNA testing would likely complement, but not replace, the current routine blood tests, reported CNN.